Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 94

1.

Scaling-up the Systems Analysis and Improvement Approach for prevention of mother-to-child HIV transmission in Mozambique (SAIA-SCALE): a stepped-wedge cluster randomized trial.

Sherr K, Ásbjörnsdóttir K, Crocker J, Coutinho J, de Fatima Cuembelo M, Tavede E, Manaca N, Ronen K, Murgorgo F, Barnabas R, John-Stewart G, Holte S, Weiner BJ, Pfeiffer J, Gimbel S.

Implement Sci. 2019 Apr 27;14(1):41. doi: 10.1186/s13012-019-0889-z.

2.

Phylogenetic Analyses Comparing HIV Sequences from Plasma at Virologic Failure to Cervix Versus Blood Sequences from Antecedent Antiretroviral Therapy Suppression.

Bull ME, McKernan JL, Styrchak S, Kraft K, Hitti J, Cohn SE, Tapia K, Deng W, Holte S, Mullins JI, Coombs RW, Frenkel LM.

AIDS Res Hum Retroviruses. 2019 Jun;35(6):557-566. doi: 10.1089/AID.2018.0211. Epub 2019 Apr 30.

PMID:
30892052
3.

Intraindividual Variation in Markers of Intestinal Permeability and Adipose Tissue Inflammation in Healthy Normal-Weight to Obese Adults.

Kuzma JN, Hagman DK, Cromer G, Breymeyer KL, Roth CL, Foster-Schubert KE, Holte SE, Weigle DS, Kratz M.

Cancer Epidemiol Biomarkers Prev. 2019 Mar;28(3):610-615. doi: 10.1158/1055-9965.EPI-18-0641. Epub 2018 Dec 20.

PMID:
30573517
4.

Consuming glucose-sweetened, not fructose-sweetened, beverages increases fasting insulin in healthy humans.

Kuzma JN, Cromer G, Hagman DK, Breymeyer KL, Roth CL, Foster-Schubert KE, Holte SE, Weigle DS, Kratz M.

Eur J Clin Nutr. 2019 Mar;73(3):487-490. doi: 10.1038/s41430-018-0297-5. Epub 2018 Aug 30.

5.

HIV DNA levels and decay in a cohort of 111 long-term virally suppressed patients.

Golob JL, Stern J, Holte S, Kitahata MM, Crane HM, Coombs RW, Goecker E, Woolfrey AE, Harrington RD.

AIDS. 2018 Sep 24;32(15):2113-2118. doi: 10.1097/QAD.0000000000001948.

PMID:
30005008
6.

No Time to Delay! Fiebig Stages and Referral in Acute HIV infection: Seattle Primary Infection Program Experience.

Stekler JD, Tapia K, Maenza J, Stevens CE, Ure GA, O'Neal JD, Lane A, Mullins JI, Coombs RW, Holte S, Collier AC.

AIDS Res Hum Retroviruses. 2018 Aug;34(8):657-666. doi: 10.1089/AID.2017.0276. Epub 2018 Jun 13.

PMID:
29756456
7.

Monotypic low-level HIV viremias during antiretroviral therapy are associated with disproportionate production of X4 virions and systemic immune activation.

Bull ME, Mitchell C, Soria J, Styrchak S, Williams-Wietzikoski C, Legard J, McKernan-Mullin J, Kraft K, Onchiri F, Stern J, Holte S, Ryan KJ, Acosta EP, La Rosa A, Coombs RW, Ticona E, Frenkel LM.

AIDS. 2018 Jul 17;32(11):1389-1401. doi: 10.1097/QAD.0000000000001824.

8.

Stress Among Latinos: Does it Vary by Occupation and Agricultural Season?

Ulrich A, Molina Y, Briant KJ, Onstad LE, Copeland W, Holte SE, Thompson B.

J Occup Environ Med. 2018 Sep;60(9):810-814. doi: 10.1097/JOM.0000000000001333.

PMID:
29634611
9.

Transmission of HIV-1 drug resistance mutations within partner-pairs: A cross-sectional study of a primary HIV infection cohort.

Stekler JD, Milne R, Payant R, Beck I, Herbeck J, Maust B, Deng W, Tapia K, Holte S, Maenza J, Stevens CE, Mullins JI, Collier AC, Frenkel LM.

PLoS Med. 2018 Mar 27;15(3):e1002537. doi: 10.1371/journal.pmed.1002537. eCollection 2018 Mar.

10.

Together We STRIDE: A quasi-experimental trial testing the effectiveness of a multi-level obesity intervention for Hispanic children in rural communities.

Ko LK, Rillamas-Sun E, Bishop S, Cisneros O, Holte S, Thompson B.

Contemp Clin Trials. 2018 Apr;67:81-86. doi: 10.1016/j.cct.2018.02.013. Epub 2018 Mar 5.

11.

How Well Do Neurologic Symptoms Identify Individuals With Neurosyphilis?

Davis AP, Stern J, Tantalo L, Sahi S, Holte S, Dunaway S, Marra CM.

Clin Infect Dis. 2018 Jan 18;66(3):363-367. doi: 10.1093/cid/cix799.

12.

Symmetric Directional False Discovery Rate Control.

Holte SE, Lee EK, Mei Y.

Stat Methodol. 2016 Dec;33:71-82. doi: 10.1016/j.stamet.2016.08.002. Epub 2016 Aug 24.

13.

Results of a randomized controlled trial to increase cervical cancer screening among rural Latinas.

Thompson B, Carosso EA, Jhingan E, Wang L, Holte SE, Byrd TL, Benavides MC, Lopez C, Martinez-Gutierrez J, Ibarra G, Gonzalez VJ, Gonzalez NE, Duggan CR.

Cancer. 2017 Feb 15;123(4):666-674. doi: 10.1002/cncr.30399. Epub 2016 Oct 27.

14.

No differential effect of beverages sweetened with fructose, high-fructose corn syrup, or glucose on systemic or adipose tissue inflammation in normal-weight to obese adults: a randomized controlled trial.

Kuzma JN, Cromer G, Hagman DK, Breymeyer KL, Roth CL, Foster-Schubert KE, Holte SE, Weigle DS, Kratz M.

Am J Clin Nutr. 2016 Aug;104(2):306-14. doi: 10.3945/ajcn.115.129650. Epub 2016 Jun 29.

15.

Epidemiology and Health-Related Quality of Life in Hypoparathyroidism in Norway.

Astor MC, Løvås K, Debowska A, Eriksen EF, Evang JA, Fossum C, Fougner KJ, Holte SE, Lima K, Moe RB, Myhre AG, Kemp EH, Nedrebø BG, Svartberg J, Husebye ES.

J Clin Endocrinol Metab. 2016 Aug;101(8):3045-53. doi: 10.1210/jc.2016-1477. Epub 2016 May 17.

16.

The role of diet in children's exposure to organophosphate pesticides.

Holme F, Thompson B, Holte S, Vigoren EM, Espinoza N, Ulrich A, Griffith W, Faustman EM.

Environ Res. 2016 May;147:133-40. doi: 10.1016/j.envres.2016.02.003. Epub 2016 Feb 11.

17.

A Pilot Study of Raltegravir Plus Combination Antiretroviral Therapy in Early Human Immunodeficiency Virus Infection: Challenges and Lessons Learned.

Collier AC, Chun TW, Maenza J, Coombs RW, Tapia K, Chang M, Stevens CE, Justement JS, Murray D, Stekler JD, Mullins JI, Holte SE.

Biores Open Access. 2016 Jan 1;5(1):15-21. doi: 10.1089/biores.2015.0038. eCollection 2016.

18.

Understanding the impact of colorectal cancer education: a randomized trial of health fairs.

Briant KJ, Wang L, Holte S, Ramos A, Marchello N, Thompson B.

BMC Public Health. 2015 Nov 30;15:1196. doi: 10.1186/s12889-015-2499-2.

19.

No difference in ad libitum energy intake in healthy men and women consuming beverages sweetened with fructose, glucose, or high-fructose corn syrup: a randomized trial.

Kuzma JN, Cromer G, Hagman DK, Breymeyer KL, Roth CL, Foster-Schubert KE, Holte SE, Callahan HS, Weigle DS, Kratz M.

Am J Clin Nutr. 2015 Dec;102(6):1373-80. doi: 10.3945/ajcn.115.116368. Epub 2015 Nov 4.

20.

How often does treatment of primary HIV lead to post-treatment control?

Maenza J, Tapia K, Holte S, Stekler JD, Stevens CE, Mullins JI, Collier AC.

Antivir Ther. 2015;20(8):855-63. doi: 10.3851/IMP2963. Epub 2015 Apr 23.

21.

HIV-1 shedding from the female genital tract is associated with increased Th1 cytokines/chemokines that maintain tissue homeostasis and proportions of CD8+FOXP3+ T cells.

Bull ME, Legard J, Tapia K, Sorensen B, Cohn SE, Garcia R, Holte SE, Coombs RW, Hitti JE.

J Acquir Immune Defic Syndr. 2014 Dec 1;67(4):357-64. doi: 10.1097/QAI.0000000000000336.

22.

Antibodies to PfSEA-1 block parasite egress from RBCs and protect against malaria infection.

Raj DK, Nixon CP, Nixon CE, Dvorin JD, DiPetrillo CG, Pond-Tor S, Wu HW, Jolly G, Pischel L, Lu A, Michelow IC, Cheng L, Conteh S, McDonald EA, Absalon S, Holte SE, Friedman JF, Fried M, Duffy PE, Kurtis JD.

Science. 2014 May 23;344(6186):871-7. doi: 10.1126/science.1254417.

23.

Lack of resistance to integrase inhibitors among antiretroviral-naive subjects with primary HIV-1 infection, 2007-2013.

Stekler JD, McKernan J, Milne R, Tapia KA, Mykhalchenko K, Holte S, Maenza J, Stevens CE, Buskin SE, Mullins JI, Frenkel LM, Collier AC.

Antivir Ther. 2015;20(1):77-80. doi: 10.3851/IMP2780. Epub 2014 May 15.

24.

Parasite burden and severity of malaria in Tanzanian children.

Gonçalves BP, Huang CY, Morrison R, Holte S, Kabyemela E, Prevots DR, Fried M, Duffy PE.

N Engl J Med. 2014 May 8;370(19):1799-808. doi: 10.1056/NEJMoa1303944.

25.

Impact of mutations in highly conserved amino acids of the HIV-1 Gag-p24 and Env-gp120 proteins on viral replication in different genetic backgrounds.

Liu Y, Rao U, McClure J, Konopa P, Manocheewa S, Kim M, Chen L, Troyer RM, Tebit DM, Holte S, Arts EJ, Mullins JI.

PLoS One. 2014 Apr 8;9(4):e94240. doi: 10.1371/journal.pone.0094240. eCollection 2014.

26.

Increasing cervical cancer screening in the United States-Mexico border region.

Thompson B, Vilchis H, Moran C, Copeland W, Holte S, Duggan C.

J Rural Health. 2014 Spring;30(2):196-205. doi: 10.1111/jrh.12044. Epub 2013 Aug 12.

27.

Change in peripheral blood leukocyte telomere length and mortality in breast cancer survivors.

Duggan C, Risques R, Alfano C, Prunkard D, Imayama I, Holte S, Baumgartner K, Baumgartner R, Bernstein L, Ballard-Barbash R, Rabinovitch P, McTiernan A.

J Natl Cancer Inst. 2014 Apr;106(4):dju035. doi: 10.1093/jnci/dju035. Epub 2014 Mar 13.

28.

Diabetes prevention in Hispanics: report from a randomized controlled trial.

Duggan C, Carosso E, Mariscal N, Islas I, Ibarra G, Holte S, Copeland W, Linde S, Thompson B.

Prev Chronic Dis. 2014 Feb 27;11:E28. doi: 10.5888/pcd11.130119.

29.

Successful isolation of infectious and high titer human monocyte-derived HIV-1 from two subjects with discontinued therapy.

Wang T, Xu Y, Zhu H, Andrus T, Ivanov SB, Pan C, Dolores J, Dann GC, Zhou M, Forte D, Yang Z, Holte S, Corey L, Zhu T.

PLoS One. 2013 May 31;8(5):e65071. doi: 10.1371/journal.pone.0065071. Print 2013.

30.

Human immunodeficiency viruses appear compartmentalized to the female genital tract in cross-sectional analyses but genital lineages do not persist over time.

Bull ME, Heath LM, McKernan-Mullin JL, Kraft KM, Acevedo L, Hitti JE, Cohn SE, Tapia KA, Holte SE, Dragavon JA, Coombs RW, Mullins JI, Frenkel LM.

J Infect Dis. 2013 Apr 15;207(8):1206-15. doi: 10.1093/infdis/jit016. Epub 2013 Jan 11.

31.

A sensitive real-time PCR based assay to estimate the impact of amino acid substitutions on the competitive replication fitness of human immunodeficiency virus type 1 in cell culture.

Liu Y, Holte S, Rao U, McClure J, Konopa P, Swain JV, Lanxon-Cookson E, Kim M, Chen L, Mullins JI.

J Virol Methods. 2013 Apr;189(1):157-66. doi: 10.1016/j.jviromet.2012.10.016. Epub 2012 Nov 29.

32.

HIV-1 RNA may decline more slowly in semen than in blood following initiation of efavirenz-based antiretroviral therapy.

Graham SM, Holte SE, Dragavon JA, Ramko KM, Mandaliya KN, McClelland RS, Peshu NM, Sanders EJ, Krieger JN, Coombs RW.

PLoS One. 2012;7(8):e43086. doi: 10.1371/journal.pone.0043086. Epub 2012 Aug 13.

33.

Do workplace and home protective practices protect farm workers? Findings from the "For Healthy Kids" study.

Coronado GD, Holte SE, Vigoren EM, Griffith WC, Barr DB, Faustman EM, Thompson B.

J Occup Environ Med. 2012 Sep;54(9):1163-9.

34.

Are there benefits to starting antiretroviral therapy during primary HIV infection? Conclusions from the Seattle Primary Infection Cohort vary by control group.

Stekler JD, Wellman R, Holte S, Maenza J, Stevens CE, Corey L, Collier AC.

Int J STD AIDS. 2012 Mar;23(3):201-6. doi: 10.1258/ijsa.2011.011178.

35.

Efficient use of longitudinal CD4 counts and viral load measures in survival analysis.

Holte SE, Randolph TW, Ding J, Tien J, McClelland RS, Baeten JM, Overbaugh J.

Stat Med. 2012 Aug 30;31(19):2086-97. doi: 10.1002/sim.5318. Epub 2012 Mar 13.

36.

Iron deficiency protects against severe Plasmodium falciparum malaria and death in young children.

Gwamaka M, Kurtis JD, Sorensen BE, Holte S, Morrison R, Mutabingwa TK, Fried M, Duffy PE.

Clin Infect Dis. 2012 Apr;54(8):1137-44. doi: 10.1093/cid/cis010. Epub 2012 Feb 21.

37.

Incidence and correlates of HIV-1 RNA detection in the breast milk of women receiving HAART for the prevention of HIV-1 transmission.

Slyker JA, Chung MH, Lehman DA, Kiarie J, Kinuthia J, Holte S, Tapia K, Njiri F, Overbaugh J, John-Stewart G.

PLoS One. 2012;7(1):e29777. doi: 10.1371/journal.pone.0029777. Epub 2012 Jan 11.

38.

Prevalence and impact of minority variant drug resistance mutations in primary HIV-1 infection.

Stekler JD, Ellis GM, Carlsson J, Eilers B, Holte S, Maenza J, Stevens CE, Collier AC, Frenkel LM.

PLoS One. 2011;6(12):e28952. doi: 10.1371/journal.pone.0028952. Epub 2011 Dec 16.

39.

Identifying the early post-HIV antibody seroconversion period.

Hecht FM, Wellman R, Busch MP, Pilcher CD, Norris PJ, Margolick JB, Collier AC, Little SJ, Markowitz M, Routy JP, Holte S; Acute Infection Early Disease Research Program.

J Infect Dis. 2011 Aug 15;204(4):526-33. doi: 10.1093/infdis/jir304.

40.

Organophosphate pesticide exposure and residential proximity to nearby fields: evidence for the drift pathway.

Coronado GD, Holte S, Vigoren E, Griffith WC, Barr DB, Faustman E, Thompson B.

J Occup Environ Med. 2011 Aug;53(8):884-91. doi: 10.1097/JOM.0b013e318222f03a.

41.

IL28B genotype effects during early treatment with peginterferon and ribavirin in difficult-to-treat hepatitis C virus infection.

Scott J, Holte S, Urban T, Burgess C, Coppel E, Wang C, Corey L, McHutchison J, Goldstein D.

J Infect Dis. 2011 Aug 1;204(3):419-25. doi: 10.1093/infdis/jir264.

42.

Dynamics of viral evolution and CTL responses in HIV-1 infection.

Liu Y, McNevin JP, Holte S, McElrath MJ, Mullins JI.

PLoS One. 2011 Jan 20;6(1):e15639. doi: 10.1371/journal.pone.0015639.

43.

Post-prostatic massage fluid/urine as an alternative to semen for studying male genitourinary HIV-1 shedding.

Graham SM, Krieger JN, Githua PL, Wamuyu LW, Wale S, Ramko KM, Dragavon JA, Muller CH, Holte SE, Mandaliya KN, McClelland RS, Peshu NM, Sanders EJ, Coombs RW.

Sex Transm Infect. 2011 Apr;87(3):232-7. doi: 10.1136/sti.2010.047118. Epub 2011 Jan 29.

44.

Cervicovaginal shedding of hepatitis C viral RNA is associated with the presence of menstrual or other blood in cervicovaginal fluids.

Wang CC, Cook L, Tapia KA, Holte S, Krows M, Bagabag A, Santos A, Corey L, Jerome KR.

J Clin Virol. 2011 Jan;50(1):4-7. doi: 10.1016/j.jcv.2010.09.009. Epub 2010 Oct 15.

PMID:
20951635
45.

Strategies for increasing mammography screening in primary care in Chile: results of a randomized clinical trial.

Püschel K, Coronado G, Soto G, Gonzalez K, Martinez J, Holte S, Thompson B.

Cancer Epidemiol Biomarkers Prev. 2010 Sep;19(9):2254-61. doi: 10.1158/1055-9965.EPI-10-0313.

46.

Compartmentalization of HIV-1 within the female genital tract is due to monotypic and low-diversity variants not distinct viral populations.

Bull M, Learn G, Genowati I, McKernan J, Hitti J, Lockhart D, Tapia K, Holte S, Dragavon J, Coombs R, Mullins J, Frenkel L.

PLoS One. 2009 Sep 22;4(9):e7122. doi: 10.1371/journal.pone.0007122.

47.

Monotypic human immunodeficiency virus type 1 genotypes across the uterine cervix and in blood suggest proliferation of cells with provirus.

Bull ME, Learn GH, McElhone S, Hitti J, Lockhart D, Holte S, Dragavon J, Coombs RW, Mullins JI, Frenkel LM.

J Virol. 2009 Jun;83(12):6020-8. doi: 10.1128/JVI.02664-08. Epub 2009 Apr 1.

48.

A decrease in albumin in early SIV infection is related to viral pathogenicity.

Graham SM, Holte S, Kimata JT, Wener MH, Overbaugh J.

AIDS Res Hum Retroviruses. 2009 Apr;25(4):433-40. doi: 10.1089/aid.2008.0267.

49.

Genetic drift of HIV populations in culture.

Voronin Y, Holte S, Overbaugh J, Emerman M.

PLoS Genet. 2009 Mar;5(3):e1000431. doi: 10.1371/journal.pgen.1000431. Epub 2009 Mar 20.

50.

HIV dynamics in seminal plasma during primary HIV infection.

Stekler J, Sycks BJ, Holte S, Maenza J, Stevens CE, Dragavon J, Collier AC, Coombs RW.

AIDS Res Hum Retroviruses. 2008 Oct;24(10):1269-74. doi: 10.1089/aid.2008.0014.

Supplemental Content

Support Center